These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2012-001609-25 A RandomizEd, Double-masked, Placebo-controlled Study of the SafetY and Efficacy of GevokizUmAb in the TReatment of Subjects with Non-infectious IntermeDiate, Posterior, or Pan- uveitis Currently Cont... 2015-11-11 due-trials
Not reported 2012-001610-42 A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis 2015-11-11 due-trials
Ongoing, reported early 2015-002847-32 A Single-Dose Open-Label Study of XOMA 358 in Subjects with Congenital Hyperinsulinism (HI) not-yet-due
Completed, but no date 2015-005751-27 A Multi-Center, Open-Label, Randomized, Single-Dose, Controlled Trial of Intravenously Administered XOMA 213 in Suppression of Lactation after Delivery in Postpartum Women bad-data
Reported results 2016-001275-80 An Open-Label Study of XOMA 358, with Optional Dose Escalation, in Patients with Congenital Hyperinsulinism 2017-01-20 due-trials
Ongoing 2016-004186-83 An Open-Label Multiple-Dose Study of XOMA 358 in Patients with Congenital Hyperinsulinism not-yet-due